Geriatric oncology: comparing health related quality of life in head and neck cancer patients

Abstract

BackgroundPopulation ageing is increasing the number of people annually diagnosed with cancer worldwide, once most types of tumours are age-dependent. High-quality healthcare in geriatric oncology requires a multimodal approach and should take into account stratified patient outcomes based on factors other than chronological age in order to develop interventions able to optimize oncology care.This study aims to evaluate the Health Related Quality of Life in head and neck cancer patients and compare the scores in geriatric and younger patients.MethodsTwo hundred and eighty nine head and neck cancer patients from the Oncology Portuguese Institute participated in the Health Related Quality of Life assessment. Two patient groups were considered: the geriatric (≥ 65 years old, n = 115) and the younger (45-60 years old, n= 174). The EORTC QLQ-C30 and EORTC QLQ-H&N35 questionnaires were used.ResultsHead and neck cancer patients were mostly males, 77.4% within geriatric group and 91.4% among younger patients group.The most frequent tumour locations were similar in both groups: larynx, oral cavity and oropharynx - base of the tongue.At the time of diagnosis, most of younger male patients were at disease stage III/IV (55.9%) whereas the majority of younger female patients were at disease stage I/II (83.4%). The geriatric patient distribution was found to be similar in any of the four disease stages and no gender differences were observed.We found that age (geriatrics scored generally worse), gender (females scored generally worse), and tumour site (larynx tumours denounce more significant problems between age groups) clearly influences Health Related Quality of Life perceptions.ConclusionsGeriatric oncology assessments signalize age-independent indicators that might guide oncologic geriatric care optimization. Decision-making in geriatric oncology must be based on tumour characteristics and chronological age but also on performance status evaluation, co-morbidity, and patient reported outcomes assessment.

Squamous cell carcinoma of the tongue in a female with advanced breast cancer: A case report of an elderly patient presenting with two types of cancer

“…This mode of conduct is similar to that which was proposed in a recent study regarding geriatric patients with HNC (10). …”

Osteosarcoma: A Comparison of Jaw versus Nonjaw Localizations and Review of the Literature

“…Due to the number of patients treated with radiotherapy and the decreasing dosages and smaller fields of irradiation currently used, it is likely that the number of secondary tumors will decrease in the coming decades. The lower percentage in older patients treated with multimodality treatment can be explained by the choice of both physicians and older patients to go for care instead of cure in these often frail patients [38–40]. Localization in the maxillary region exceeded mandible localizations, which is not in line with other publications [41].…”

Diagnoses of 964 oral biopsies from people aged over 50 years in Karnataka State, India

“…On studying the various lesion groups, it was noted that malignancies and potentially malignant disorders (PMD) were the most predominant lesions and they envelop a huge margin of geriatric cases (62%) reporting to the institution of which malignant epithelial neoplasms such as oral squamous carcinoma (94%) account for the major group of lesions. Frequent mutations and hypomethylation of the DNA known to occur in ageing population, are predisposing factors for tumour cell transformation and oncogene activation, thereby favouring tumorigenesis. Studies have also shown that old are more likely to develop cancer.…”

“…Frequent mutations and hypomethylation of the DNA known to occur in ageing population, are predisposing factors for tumour cell transformation and oncogene activation, thereby favouring tumorigenesis. Studies have also shown that old are more likely to develop cancer. Head and neck oral squamous cell carcinoma is rising rapidly in India, and with the concurrent rise in geriatric population, geriatric oncologies are likely to be the most formidable mortality factor in future.…”